Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Female Sexual Function Research PT-141 is studied in female research models for effects on sexual arousal, desire, and responsiveness applications that led to Bremelanotide's eventual development as a pharmaceutical intervention for hypoactive sexual desire disorder (HSDD) in premenopausal women
Restrictions apply
Instead, they represent a distinct approach targeting craving, cue salience (what the brain pays attention to), and shared reward circuitry
Documentation note: A reported HPLC purity percentage does not by itself establish identity, quantity, sterility or suitability for a particular application
INDIVIDUAL & FAMILY Your Pharmacy Benefits Find your covered prescriptions, ways to save and next steps with your doctor or pharmacist
US$ 23.32
US$ 20.52
US$ 20.94
US$ 22.56
